Leslie Leinwand, PhD

Distinguished Professor of Molecular, Cellular, and Developmental Biology; and Chief Scientific Officer of the BioFrontiers Institute at the University of Colorado Boulder; and a Professor at The Howard Hughes Medical Institute. Dr. Leinwand is the co-founder of Myogen (acquired by Gilead for $2.5B) and MyoKardia (acquired by Bristol Myers Squibb for $13B).